Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course

Rachel E. Harris, Marina Aloi, Lissy De Ridder, Nicholas M. Croft, Sibylle Koletzko, Arie Levine, Dan Turner, Gigi Veereman, Mattias Neyt, Laetitia Bigot, Frank M. Ruemmele, Richard K. Russell

Tel Aviv University, The Hebrew University of Jerusalem

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course'. Together they form a unique fingerprint.

Medicine & Life Sciences